← Open Payments lookup

AMY NELSON: Open Payments

NPI 1144831579 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,636 in 197 payments from 16 companies in 2025. Trend: 2023 $1,030 · 2024 $1,590 · 2025 $3,636

Food & beverage: $3,598Education: $39
CompanyPaymentsAmount
ABBVIE INC.47$715
Otsuka America Pharmaceutical, Inc.27$529
Axsome Therapeutics, Inc.22$455
Neurocrine BioSciences, Inc.13$345
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$323
Janssen Pharmaceuticals, Inc9$253
Teva Pharmaceuticals USA, Inc.12$242
Alkermes, Inc.10$171
Vanda Pharmaceuticals Inc.9$161
Takeda Pharmaceuticals U.S.A., Inc.15$147

Products named: VRAYLAR, REXULTI, Auvelity, INGREZZA, CAPLYTA, AUSTEDO XR, INVEGA SUSTENNA, FANAPT.

Industry payments across TX — which companies pay providers there.